Azelastin Fluticason Spirig HC Nasenspray, Suspension
7680689800011
CH-68980
suspension
Associated product:
AZELASTINE FLUTICASO Spirig HC 0.14/0.05mg 120 dos
1 / 3
google
Article details
- Package size
- 25
- Selling units
- 25
- Measure
- ml
- Galenic form
- suspension
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.137 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.05 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.014 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 31.20
Specialties list
Yes
Generic
Yes
SL addition date:
01/03/2024
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 68980
- Drug name
- Azelastin Fluticason Spirig HC Nasenspray, Suspension
- Galenic form
- NASSS
- ATC Code
- R01AD58
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 18/12/2023
- Authorization expiration date
- 17/12/2028
- IT Number
- 12.02.2.
- Domain
- Human medicine
Package details
- Description (FR)
- AZELASTINE FLUTICASO Spirig HC 0.14/0.05mg 120 dos
- Description (DE)
- AZELASTIN FLUTICASON Spirig HC 0.14/0.05mg 120 Dos
- Market launch
- 18/12/2023
- Narcotic (BTM)
- No
Original drug
Dymista Nasenspray, Suspension
GTIN: 7680626750010
CHF 34.65